BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 7769732)

  • 21. Infrapopliteal polytetrafluoroethylene and composite bypass: factors influencing patency.
    Fichelle JM; Marzelle J; Colacchio G; Gigou F; Cormier F; Cormier JM
    Ann Vasc Surg; 1995 Mar; 9(2):187-96. PubMed ID: 7786705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aortobifemoral bypass grafting using expanded polytetrafluoroethylene stretch grafts in patients with occlusive atherosclerotic disease.
    Chiesa R; Marone EM; Tshomba Y; Logaldo D; Castellano R; Melissano G
    Ann Vasc Surg; 2009; 23(6):764-9. PubMed ID: 19540713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Short Series of Laparoscopic Mesenteric Bypasses for Chronic Mesenteric Ischemia.
    Kazmi SSH; Berge ST; Sahba M; Medhus AW; Sundhagen JO
    Vasc Health Risk Manag; 2020; 16():87-97. PubMed ID: 32256075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of femorocrural bypasses performed with modified heparin-bonded expanded polytetrafluorethylene grafts and those with great saphenous vein grafts to treat critical limb ischemia.
    Gessaroli M; Tarantini S; Leone M; Fabbri E; Panzini I
    Ann Vasc Surg; 2015 Aug; 29(6):1255-64. PubMed ID: 26025478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autogenous arterial bypass grafts: durable patency and limb salvage in patients with inframalleolar occlusive disease and end-stage renal disease.
    Treiman GS; Lawrence PF; Rockwell WB
    J Vasc Surg; 2000 Jul; 32(1):13-22. PubMed ID: 10876202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
    Rychlik IJ; Davey P; Murphy J; O'Donnell ME
    J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carotid-subclavian bypass grafting with polytetrafluoroethylene grafts for symptomatic subclavian artery stenosis or occlusion: a 20-year experience.
    AbuRahma AF; Robinson PA; Jennings TG
    J Vasc Surg; 2000 Sep; 32(3):411-8; discussion 418-9. PubMed ID: 10957647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technical consideration in the management of chronic mesenteric ischemia.
    Leke MA; Hood DB; Rowe VL; Katz SG; Kohl RD; Weaver FA
    Am Surg; 2002 Dec; 68(12):1088-92. PubMed ID: 12516815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occlusive disease associated with popliteal aneurysms: impact on long term graft patency.
    Borowicz MR; Robison JG; Elliott BM; Brothers TE; Robinson CK
    J Cardiovasc Surg (Torino); 1998 Apr; 39(2):137-40. PubMed ID: 9638994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV).
    Neufang A; Espinola-Klein C; Dorweiler B; Messow CM; Schmiedt W; Vahl CF
    J Vasc Surg; 2007 Aug; 46(2):280-8. PubMed ID: 17600663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early results of lower extremity infrageniculate revascularization with a new polytetrafluoroethylene graft.
    Alcocer F; Jordan WD; Wirthlin DJ; Whitley D
    Vascular; 2004; 12(5):318-24. PubMed ID: 15765913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term evaluation of composite sequential bypass for limb-threatening ischemia.
    McCarthy WJ; Pearce WH; Flinn WR; McGee GS; Wang R; Yao JS
    J Vasc Surg; 1992 May; 15(5):761-9; discussion 769-70. PubMed ID: 1578531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Durability of endarterectomy and antegrade grafts in the treatment of chronic visceral ischemia.
    Rapp JH; Reilly LM; Qvarfordt PG; Goldstone J; Ehrenfeld WK; Stoney RJ
    J Vasc Surg; 1986 May; 3(5):799-806. PubMed ID: 3701942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endovascular recanalization of total occlusions of the mesenteric and celiac arteries.
    Sharafuddin MJ; Nicholson RM; Kresowik TF; Amin PB; Hoballah JJ; Sharp WJ
    J Vasc Surg; 2012 Jun; 55(6):1674-81. PubMed ID: 22516890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Popliteal artery aneurysms. Factors associated with thromboembolism and graft failure.
    Martelli E; Ippoliti A; Ventoruzzo G; De Vivo G; Ascoli Marchetti A; Pistolese GR
    Int Angiol; 2004 Mar; 23(1):54-65. PubMed ID: 15156131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of a color-flow duplex surveillance program on infrainguinal vein graft patency: a five-year experience.
    Idu MM; Blankenstein JD; de Gier P; Truyen E; Buth J
    J Vasc Surg; 1993 Jan; 17(1):42-52; discussion 52-3. PubMed ID: 8421341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of infrainguinal single-segment great saphenous vein bypass for critical limb ischemia is superior to alternative autologous vein bypass, especially in patients with high operative risk.
    Arvela E; Venermo M; Söderström M; Albäck A; Lepäntalo M
    Ann Vasc Surg; 2012 Apr; 26(3):396-403. PubMed ID: 22285375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bypass to plantar and tarsal arteries: an acceptable approach to limb salvage.
    Hughes K; Domenig CM; Hamdan AD; Schermerhorn M; Aulivola B; Blattman S; Campbell DR; Scovell SD; LoGerfo FW; Pomposelli FB
    J Vasc Surg; 2004 Dec; 40(6):1149-57. PubMed ID: 15622369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pedal bypass versus tibial bypass with autogenous vein: a comparison of outcome and hemodynamic results.
    Schneider JR; Walsh DB; McDaniel MD; Zwolak RM; Besso SR; Cronenwett JL
    J Vasc Surg; 1993 Jun; 17(6):1029-38; discussion 1038-40. PubMed ID: 8505781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing infrainguinal arm vein bypass patency with duplex ultrasound surveillance and endovascular therapy.
    Armstrong PA; Bandyk DF; Wilson JS; Shames ML; Johnson BL; Back MR
    J Vasc Surg; 2004 Oct; 40(4):724-30; discussion 730-1. PubMed ID: 15472601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.